While most physicians rely on serum creatinine levels to determine kidney function, it’s not the most reliable indicator, according to a nephrologist who presented at the International Society for Computed Tomography on May 18. Instead, he suggested providers look at the estimated glomerular filtration rate (eGFR). In acutely ill patients in particular look at the changing serum creatinine (sCR) levels and not the specific values or specific eGFRs, he said.
While most physicians rely on serum creatinine levels to determine kidney function, it’s not the most reliable indicator, according to a nephrologist who presented at the International Society for Computed Tomography on May 18. Instead, he suggested providers look at the estimated glomerular filtration rate (eGFR). In acutely ill patients in particular look at the changing serum creatinine (sCR) levels and not the specific values or specific eGFRs, he said.
It’s important to screen patients prior to getting a contrast-enhanced CT to determine whether they are at risk for acute kidney injury, previously known as acute kidney failure. Acute kidney injury is defined as an abrupt loss of kidney function, usually over days, marked by changing sCR. Contrast administration can exacerbate acute kidney injury.
Dr. Steven D. Weisbord, an assistant professor of medicine in the renal section at VA Pittsburgh Healthcare System, suggests screening patients’ sCR if they have one or more of the following:
A better indication of kidney function, however, is eGFR. For instance, two patients can have the same sCr of 1.5, leading to a misinterpretation, while their eGFRs are 59 mL/min and 36 mL/min.
“Even patients with serum creatinine of 1.2 can have abnormal eGFR,” he said. “Patients can have normal serum creatinine levels and eGFRs that are very abnormal.”
Weisbord cited a study that appeared five years ago and illustrates a pronounced difference in women between sCr and eGFR. The women had sCrs of 0.9 or 1 and eGFRs that put them at the stage III chronic kidney disease, which is an eGFR of 30 to 60 (J Am Soc Nephrol 2005;16:2439-2448). In another example, women with sCr of 1.6 had eGFRs of less than 30, which is stage IV chronic kidney disease.
“Serum creatinine is not a good assessment of what the patient’s renal function is,” he said.
Study with CT Data Suggests Women with PE Have More Than Triple the One-Year Mortality Rate than Men
April 3rd 2025After a multivariable assessment including age and comorbidities, women with pulmonary embolism (PE) had a 48 percent higher risk of one-year mortality than men with PE, according to a new study involving over 33,000 patients.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Predicting Diabetes on CT Scans: What New Research Reveals with Pancreatic Imaging Biomarkers
March 25th 2025Attenuation-based biomarkers on computed tomography (CT) scans demonstrated a 93 percent interclass correlation coefficient (ICC) agreement across three pancreatic segmentation algorithms for predicting diabetes, according to a study involving over 9,700 patients.
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.